Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 25 | 13 | 13 | 13 | 12 |
| Income taxes - deferred | 0 | N/A | N/A | N/A | -5 |
| Accounts receivable | -989 | 354 | -156 | 11 | -592 |
| Accounts payable and accrued liabilities | -219 | 33 | 869 | 307 | 440 |
| Other Working Capital | -1,518 | 383 | 676 | 374 | -158 |
| Other Operating Activity | 1,396 | -1,396 | -1,609 | -1,051 | -246 |
| Operating Cash Flow | $-1,305 | $-612 | $-208 | $-345 | $-549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -6 | -9 | -7 | -1 |
| Purchase Sale Intangibles | -589 | 2 | -110 | 15 | -14 |
| Other Investing Activity | 0 | 0 | 0 | 35 | 316 |
| Investing Cash Flow | $-591 | $-4 | $-119 | $8 | $336 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -788 | 185 | -170 | 350 | -539 |
| Debt Issued | -80 | 430 | 550 | 21 | 789 |
| Other Financing Activity | 2,759 | -14 | -45 | -37 | -26 |
| Financing Cash Flow | $1,891 | $601 | $335 | $334 | $224 |
| Exchange Rate Effect | 5 | 16 | -20 | -1 | -3 |
| Beginning Cash Position | 0 | 0 | 11 | 16 | 8 |
| End Cash Position | 0 | 0 | 0 | 11 | 16 |
| Net Cash Flow | $-5 | $-16 | $9 | $-3 | $11 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,305 | -612 | -208 | -345 | -549 |
| Capital Expenditure | -591 | -4 | -119 | -27 | N/A |
| Free Cash Flow | -1,896 | -616 | -327 | -373 | -549 |